FDA Opioid Policy: Senate Takes A Speak Softly Approach
This article was originally published in The Pink Sheet Daily
Executive Summary
Senate Appropriations Committee says FDA should finalize draft abuse-deterrent opioids guidance, but unlike House, does not make funding contingent on completion.